Seratio Blockchain: Values Based Impact Interventions Maryam Taghiyeva MA Dr Kelig Aujogue PhD Dr Haley Beer PhD Barbara Mellish MBA ACIB MIRM Prof Olinga Ta’eed PhD FIoD Seratio Blockchain White Paper 2.14 Essential Reading: Seratio Blockchain 1.0 white paper 'Currency of Intangible Non-Financial Value' 1 Description: Modelling and forecasting of both tangible and intangible impact through the use of Seratio® blockchain, leading to intervention solutions through forecasting

Autor: Olinga Taeed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e6379381602a49a442d6148a7aa364a5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Critical conversations as a tool for students' tacit knowledge construction: An interpretive research in interior design studio interactions

Autor: Venkatesh, Dr. Aruna, Ma, Dr. Henry

Publikováno v: In International Journal of Educational Research Open 2021 2

Anemia, blood cell indices, genetic correlations, and brain structures: A comprehensive analysis of roles in Parkinson's disease risk.

Autor: Zuo CY; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Hao XY; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; Academy of Medical Sciences of Zhengzhou University, Zhengzhou, 450000, Henan, China., Li MJ; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; Academy of Medical Sciences of Zhengzhou University, Zhengzhou, 450000, Henan, China., Guo MN; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Ma DR; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Li SJ; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Liang YY; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Hao CW; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Wang ZY; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Feng YM; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Sun YM; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China., Xu YM; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; Institute of Neuroscience, Zhengzhou University, Zhengzhou, 450000, Henan, China., Shi CH; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China; Institute of Neuroscience, Zhengzhou University, Zhengzhou, 450000, Henan, China. Electronic address: shichanghe@gmail.com.

Publikováno v: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2024 Sep 18; Vol. 128, pp. 107153. Date of Electronic Publication: 2024 Sep 18.

Targeting heterozygous dominant negative variant of KCNA2 using Gapmer ASO for the treatment of drug-resistant epilepsy.

Autor: Huang H; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.; Electrophysiology Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117544, Singapore.; LSI Neurobiology Programme, National University of Singapore, Singapore 117456, Singapore.; Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore: Level 5, Centre for Life Sciences, 28 Medical Drive, Singapore 117456, Singapore.; Cardiovascular-Metabolic Disease Translational Research Programme, National University of Singapore, 14 Medical Drive, MD6, #08-01, Singapore 117599, Singapore., Ma DR; Department of Neurology, Singapore General Hospital, Singapore 169856, Singapore.; DUKE-NUS Medical School, Singapore 169857, Singapore., Chan DWS; Paediatric Neurology, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore., Ngoh ASF; Paediatric Neurology, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore., Yu D; Electrophysiology Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117544, Singapore., Ng SJ; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore., En Chua JJ; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.; LSI Neurobiology Programme, National University of Singapore, Singapore 117456, Singapore.; Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore: Level 5, Centre for Life Sciences, 28 Medical Drive, Singapore 117456, Singapore., Tan EK; Neuroscience and Behavioral Disorder, DUKE-NUS Medical School, Singapore 169857, Singapore.; National Neuroscience Institute, Department of Neurology, Singapore 308433, Singapore., Chin HL; Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Goh DLM; Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Soong TW; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.; LSI Neurobiology Programme, National University of Singapore, Singapore 117456, Singapore.; Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore: Level 5, Centre for Life Sciences, 28 Medical Drive, Singapore 117456, Singapore.; Cardiovascular-Metabolic Disease Translational Research Programme, National University of Singapore, 14 Medical Drive, MD6, #08-01, Singapore 117599, Singapore.

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 Aug 27; Vol. 35 (4), pp. 102316. Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).